"Real world" patient data documents the long-term effects of ALK vaccines
In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers.
BY ALBERT RØNNING-ANDERSSON, translated by Ingrid Greenhow
In the health policy debate on the introduction of new drugs and vaccines, real-world evidence(RWE) is often highlighted as a solution to challenges in documenting the effects of new drugs.